Harnal and upper respiratory tract inflammation Patient Reports February 13, 2012

Harnal Side Effects Report #4567977-5
Harnal side effect was reported by a Consumer or non-health professional from on Jan 18, 2005. Male patient, 80 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive, upper respiratory tract inflammation. Harnal dosage: 0.2 MG (3 G, 0.2. MG QD, 3G) PO. During the same period patient was treated with RANITIDINE. Patient died.

Harnal Side Effects Report #4589728-0
Harnal side effect was reported by a Consumer or non-health professional from on Feb 04, 2005. Male patient, 80 years of age, was diagnosed with benign prostatic hyperplasia, nasopharyngitis and was treated with Harnal. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive, nasopharyngitis, upper respiratory tract inflammation. Harnal dosage: (SEE TEXT, 0.2 MG QD PO. During the same period patient was treated with PL GRANULE, RANITIDINE HYDROCHLORIDE, RYUTAN, PRULIFLOXACIN, BROTIZOLAM. Patient died.

Harnal Side Effects Report #4924554-1
Harnal side effect was reported by a Physician from JAPAN on Feb 08, 2006. Male patient, weighting 154.3 lb, was diagnosed with benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: face oedema, glossodynia, hyperthermia, upper respiratory tract inflammation. Harnal dosage: unknown. During the same period patient was treated with KETOPROFEN, BLOPRESS, PROTECADIN, LEXIN. Patient was hospitalized. Patient recovered.